Analysis of Patient-Reported Outcomes (Pros) for Gog-258, a Randomized Phase Iii Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel (Cis-Rt+Cp) Vs. Carboplatin and Paclitaxel (Cp) for Optimally Debulked, Locally Advanced Endometrial Carcinoma: A Gynecologic Oncology Group/Nrg Study.
AuthID
P-00V-TBA
P-00V-TBA